GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dechra Pharmaceuticals PLC (OTCPK:DCHPF) » Definitions » Institutional Ownership

Dechra Pharmaceuticals (Dechra Pharmaceuticals) Institutional Ownership : 29.38% (As of Jun. 06, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Dechra Pharmaceuticals Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Dechra Pharmaceuticals's institutional ownership is 29.38%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Dechra Pharmaceuticals's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Dechra Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 0.00%.


Dechra Pharmaceuticals Institutional Ownership Historical Data

The historical data trend for Dechra Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dechra Pharmaceuticals Institutional Ownership Chart

Dechra Pharmaceuticals Historical Data

The historical data trend for Dechra Pharmaceuticals can be seen below:

2023-03-31 2023-04-30 2023-05-31 2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31
Institutional Ownership 61.04 54.73 51.18 42.29 37.89 35.54 30.64 30.29 29.41 29.38

Dechra Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Dechra Pharmaceuticals (Dechra Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
24 Cheshire Avenue, Cheshire Business Park, Lostock Gralam, Northwich, GBR, CW9 7UA
Dechra Pharmaceuticals PLC is a major drug manufacturing company with a focus on veterinary pharmaceutical products. The company develops, manufactures, and markets its products exclusively for veterinarians globally. Dechra is structured along three segments, including being European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The vast majority of Dechra's revenue is generated in Europe, followed by the U.S. Dechra derives most of its revenue through its Companion Animal Product category, followed by food-producing animal products.

Dechra Pharmaceuticals (Dechra Pharmaceuticals) Headlines

From GuruFocus

Ron Baron Comments on Dechra Pharmaceuticals

By Sydnee Gatewood Sydnee Gatewood 07-29-2020

Ron Baron Comments on Dechra Pharmaceuticals PLC

By Holly LaFon Holly LaFon 01-24-2019